Oxygen carriers ('blood substitutes')

Topfer L-A, Hailey D
Record ID 32001000962
English, French
Authors' objectives:

To summarise the available evidence on the use of oxygen carriers, or 'blood substitutes'.

Authors' recommendations: - A number of oxygen carriers, or 'blood substitutes', are undergoing clinical trials. One product (Hemopure(R)) was recently licensed for use in South Africa. Another, (Hemolink(TM)) may soon be approved for marketing in Canada. - Most trials of oxygen carriers have focused on their use in surgery, primarily as a way to minimize the need for allogeneic blood transfusion. - The benefits of these products in comparison with other blood conservation technologies and with allogeneic blood transfusion must be determined. - The safety and cost-effectiveness of these products, and the patient populations that would benefit most from their use require further study.
Authors' methods: Overview
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Blood Substitutes
  • Costs and Cost Analysis
  • General Surgery
  • Oxygen
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Coordinating Office for Health Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.